CLA antagonized HFD-induced suppression in the mRNA expression of Cpt1b and Mttp, and prevented the liver dysfunction, highlighting its potential to fight against NAFLD. The gene discussed is MTTP; the disease is metabolic dysfunction-associated steatotic liver disease.